Question

Difficulty: HardBipolar and Related Disorders

Match each clinical vignette describing a medication-specific complication, adverse effect, or pharmacokinetic requirement to the most likely offending psychotropic agent used in the context of bipolar disorder.

  • A 28-year-old woman treated for bipolar I disorder presents with amenorrhea and bilateral galactorrhea. Laboratory evaluation reveals a negative serum beta-hCG and an elevated serum prolactin level.Risperidone
  • A 45-year-old man on maintenance pharmacotherapy for bipolar disorder is found to have a serum sodium of 124 mEq/L (normal: 135-145) on routine lab monitoring. He is clinically euvolemic, and his urine osmolality is elevated.Carbamazepine
  • A 32-year-old man is prescribed a second-generation antipsychotic for acute bipolar depression. To ensure adequate systemic absorption and therapeutic efficacy, the physician instructs him to take the medication with a meal of at least 350 calories.Lurasidone
  • A 50-year-old man on long-term maintenance therapy complains of excessive thirst and urinating 6 to 8 liters per day. His urine specific gravity is low, and his symptoms do not improve after a period of water deprivation.Lithium carbonate
  • A 24-year-old woman with a history of recurrent severe depression and a first-degree relative with bipolar disorder is prescribed a selective serotonin reuptake inhibitor. Two weeks later, she requires hospitalization for severe agitation, pressured speech, and a decreased need for sleep.Fluoxetine

Answer

The correct matches are: Galactorrhea and amenorrhea with Risperidone; Euvolemic hyponatremia with Carbamazepine; Required administration with a 350-calorie meal with Lurasidone; Nephrogenic diabetes insipidus with Lithium carbonate; and Antidepressant-induced manic switch with Fluoxetine.
Each medication utilized in bipolar disorder management has a distinct profile. Risperidone is highly associated with hyperprolactinemia. Carbamazepine causes SIADH (hyponatremia). Lurasidone necessitates administration with significant food (>350 calories) for absorption. Lithium causes nephrogenic diabetes insipidus by antagonizing ADH. Fluoxetine, an SSRI, can induce an acute manic episode if given as monotherapy to a patient with bipolar disorder.

Step-by-Step Solution

1
Analyze the endocrine/reproductive vignette.
Identified hyperprolactinemia.
Among the options, Risperidone is the antipsychotic most strongly associated with tuberoinfundibular dopamine blockade and subsequent elevated prolactin.
2
Analyze the electrolyte abnormality vignette.
Identified euvolemic hyponatremia consistent with SIADH.
Carbamazepine frequently causes SIADH, requiring routine serum sodium monitoring.
3
Analyze the pharmacokinetic vignette.
Identified the specific caloric intake requirement for absorption.
Lurasidone specifically requires a minimum 350-calorie meal for adequate bioavailability; taking it on an empty stomach drastically reduces its efficacy.
4
Analyze the renal/urinary vignette.
Identified nephrogenic diabetes insipidus.
Lithium carbonate is a classic cause of acquired nephrogenic DI due to its interference with ADH action at the collecting duct, leading to massive polyuria and polydipsia.
5
Analyze the psychiatric complication vignette.
Identified an antidepressant-induced manic switch.
Fluoxetine, a selective serotonin reuptake inhibitor, should not be used as monotherapy for depression in patients with a history of or high risk for bipolar disorder due to the risk of precipitating mania.

Key Concept

Pharmacotherapy for Bipolar Disorder: Specific Adverse Effects and Administration Requirements
Rate this question